Patrick Mc Ilvenny is Chief Accounting Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 6,874 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $800,821. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Patrick McIlvenny Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2023
SELL
Sale (or disposition) back to the issuer
$800,821 $116.5 p/Share
6,874 Reduced 100.0%
0 Ordinary Shares
Jan 05 2023
SELL
Payment of exercise price or tax liability
$469,606 $113.24 p/Share
4,147 Reduced 39.63%
6,316 Ordinary Shares
Jan 05 2023
BUY
Exercise of conversion of derivative security
-
7,973 Added 43.25%
10,463 Ordinary Shares
PM

Patrick Mc Ilvenny

Chief Accounting Officer
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP